Article
PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer
15 Dec 2009
Abstract excerpt
BACKGROUND: To date individual markers have failed to correctly predict resistance against anticancer agents in breast cancer. We used gene expression patterns attributable to chemotherapy-resistant cells to detect potential new biomarkers related to anthracycline resistance. One of the genes, PSMB7, was selected for further functional studies and clinical validation. METHODS: We contrasted the expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
